Navigating the New 20% Discount Rule for Combination Drugs: What You Need to Know
The healthcare sector in Germany continues to evolve as the government introduces new measures aimed at controlling costs while maintaining access to
Category: Pricing
Determining the Reimbursed Price for Pharmaceuticals in Germany: An Overview
In April 2024, I wrote a guest post for Market Access Today. Introduction Entering the dynamic realm of pharmaceutical pricing in Germany,
Confidentiality vs. Transparency: Germany’s Drug Price Dilemma Unpacked
Are confidential drug prices coming to Germany? Until now, the reimbursed prices of drugs are in the public domain (Lauer Taxe), but
Determining the Reimbursed Price for Pharmaceuticals in Germany
Introduction Entering the dynamic realm of pharmaceutical pricing in Germany, we find ourselves immersed in a landscape defined by regulations, negotiations, price
Lung cancer drug taken off German market because of no additional benefit rating
On 25 August 2022, Janssen has announced that they have withdrawn the lung cancer drug Rybrevant (amivantamab) from the German market with